Using microbes to recover rare earths with low environmental impact?

Using Microbes to recover Rare Earths with low environmental impact Barbara Palumbo Roe, Simon Gregory, Antoni Milodowski, Julia West, Joanna Wragg British Geological Survey, Nicker Hill, Nottingham NG12 5GG, UK Steve Banwart, Maria Romero González, Wei Huang, Emma Wharfe Kroto Research Institute, University of Sheffield, Sheffield S3 7HQ, UK John Harding, Colin Freeman, Shaun Hall Department of Materials Science and Engineering, University of Sheffield, Sheffield S1 3JD, UK Microbes play an important role in the fate and transport of rare earth elements (REE) in relation to the REE exploitation life cycle. A step change in understanding is needed for key mobilisation, concentration and fractionation processes such as bioleaching, biosorption and biomineralisation and how they can 1) be harnessed to recover REE in situ from low grade ores or secondary deposits, and 2) be quantified for reactive transport in environmental risk assessment and management of mining operations. Heap/in-situ leaching methods are relatively low impact mining technologies, requiring less energy (for comminution) and in the case of in-situ leaching have a minimal footprint. Furthermore, biologically-assisted leaching and separation processes represent a more sustainable alternative to chemical processes. We discuss the microbial potential to accelerate dissolution of REEs from source minerals, and how the natural selectivity of mineral and microbial surfaces as ligands for adsorption and biomineralisation of REE dissolved species could be exploited in the recovery of REEs from fluids

Gene sequencing for pathogenic variants among adults with breast and ovarian cancer in the caribbean

Importance: Rates of breast and ovarian cancer are high in the Caribbean; however, to date, few published data quantify the prevalence of inherited cancer in the Caribbean population. Objective: To determine whether deleterious variants in genes that characterize the hereditary breast and ovarian cancer syndrome are associated with the development of breast and ovarian cancer in the English- and Creole-speaking Caribbean populations. Design, Setting, and Participants: This multisite genetic association study used data from germline genetic test results between June 2010 and June 2018 in the Bahamas, Cayman Islands, Barbados, Dominica, Jamaica, Haiti, and Trinidad and Tobago. Next-generation sequencing on a panel of 30 genes and multiplex ligation-dependent probe amplification (BRCA1 and BRCA2) were performed. Medical records were reviewed at time of study enrollment. Women and men diagnosed with breast and ovarian cancer with at least 1 grandparent born in the participating study sites were included; 1018 individuals were eligible and consented to participate in this study. Data were analyzed from November 4, 2019, to May 6, 2020. Exposures: Breast and/or ovarian cancer diagnosis Main Outcomes and Measures: Rate of inherited breast and ovarian cancer syndrome and spectrum and types of variants. Results: Of 1018 participants, 999 (98.1%) had breast cancer (mean [SD] age, 46.6 [10.8] years) and 21 (2.1%) had ovarian cancer (mean [SD] age, 47.6 [13.5] years). Three individuals declined to have their results reported. A total of 144 of 1015 (14.2%) had a pathogenic or likely pathogenic (P/LP) variant in a hereditary breast and ovarian cancer syndrome gene. A total of 64% of variant carriers had P/LP variant in BRCA1, 23% in BRCA2, 9% in PALB2 and 4% in RAD51C, CHEK2, ATM, STK11 and NBN. The mean (SD) age of variant carriers was 40.7 (9.2) compared with 47.5 (10.7) years in noncarriers. Individuals in the Bahamas had the highest proportion of hereditary breast and ovarian cancer (23%), followed by Barbados (17.9%), Trinidad (12%), Dominica (8.8%), Haiti (6.7%), Cayman Islands (6.3%), and Jamaica (4.9%). In Caribbean-born women and men with breast cancer, having a first- or second-degree family member with breast cancer was associated with having any BRCA1 or BRCA2 germline variant (odds ratio, 1.58; 95% CI, 1.24-2.01; P \u3c.001). A BRCA1 vs BRCA2 variant was more strongly associated with triple negative breast cancer (odds ratio, 6.33; 95% CI, 2.05-19.54; P =.001). Conclusions and Relevance: In this study, among Caribbean-born individuals with breast and ovarian cancer, 1 in 7 had hereditary breast and ovarian cancer. The proportion of hereditary breast and ovarian cancer varied by island and ranged from 23% in the Bahamas to 4.9% in Jamaica. Each island had a distinctive set of variants.

stain Culture Shape Habitat Pathogenicity

S-1 Figure S-1 A linear relationship between SNR of single bacterial Raman spectra and laser power-time (√� � � � ��). Points are the averages of 20 measurements with standard deviation error bars. S-2 Figure S-2 New system with higher laser power significantly reduced single cell Raman acquisition time. S-3 Figure S-3 PCA scores plot of Raman spectra of E. coli DH5α with 13 C or 15 N incorporation. C, cells with 13 C substitution; N, cells with 15 N substitution; and U, unlabeled cells. S-4 Figure S-4 Single cell Raman spectra of five oral bacterial species (60 mW, 0.5 s exposure time). S-5 Figure S-5 (A) Twenty cells were randomly chosen for SCRS measurement, each took a 0.5 s acquisition time; the total time for scanning of 20 cells was ~12 s. (B) SCRS of 12 C and 13 C cells enabled a clear differentiation of stable isotope labeled cells. S-6 Table S-1 Bacterial strains used in this stud

Technical Note pubs.acs.org/ac Raman Activated Cell Ejection for Isolation of Single Cells

ABSTRACT: We have optimized a Raman microscope to obtain a single cell Raman spectrum (SCRS) with 0.1 s acquisition time. SCRS with such short acquisition time has sufficient discriminatory ability and spectral reproducibility to differentiate cells incorporated with 13 C and 15 N and to classify five different types of bacteria isolated from the oral cavity. We also developed Raman activated cell ejection (RACE) that is assisted by laser induced forward transfer (LIFT). We have shown, for the first time, that the single cells of interest can be identified and then accurately isolated from complex microbial communities based on their SCRS. This approach can be used to sort single cells of target traits from complex samples (e.g., biofilms, soils, sludge, tissues). Learning how cells work by studying individual cells is of essential interest in cell biology. The biochemical and physiological methods, which are performed on groups of cells and provide “averaged ” information of cells, could miss vital information on the physiological dynamics, cell−cell interactions

Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size

Maternal metabolic adaptations are essential for successful pregnancy outcomes. We investigated how metabolic gestational processes are coordinated, whether there is a functional link with internal clocks, and whether disruptions are related to metabolic abnormalities in pregnancy, by studying day/night metabolic pathways in murine models and samples from pregnant women with normally grown and large-for-gestational age infants. In early mouse pregnancy, expression of hepatic lipogenic genes was up-regulated and uncoupled from the hepatic clock. In late mouse pregnancy, rhythmicity of energy metabolism-related genes in the muscle followed the patterns of internal clock genes in this tissue, and coincided with enhanced lipid transporter expression in the fetoplacental unit. Diurnal triglyceride patterns were disrupted in human placentas from pregnancies with large-for-gestational age infants and this overlapped with an increase in BMAL1 expression. Metabolic adaptations in early pregnancy are uncoupled from the circadian clock, whereas in late pregnancy, energy availability is mediated by coordinated muscle-placenta metabolic adjustments linked to internal clocks. Placental triglyceride oscillations in the third trimester of human pregnancy are lost in large-for-gestational age infants and may be regulated by BMAL1. In summary, disruptions in metabolic and circadian rhythmicity are associated with increased fetal size, with implications for the pathogenesis of macrosomia.-Papacleovoulou, G., Nikolova, V., Oduwole, O., Chambers, J., Vazquez-Lopez, M., Jansen, E., Nicolaides, K., Parker, M., Williamson, C. Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size.</p

Raman Activated Cell Ejection for Isolation of Single Cells

We have optimized a Raman microscope to obtain a single cell Raman spectrum (SCRS) with 0.1 s acquisition time. SCRS with such short acquisition time has sufficient discriminatory ability and spectral reproducibility to differentiate cells incorporated with ¹³C and ¹⁵N and to classify five different types of bacteria isolated from the oral cavity. We also developed Raman activated cell ejection (RACE) that is assisted by laser induced forward transfer (LIFT). We have shown, for the first time, that the single cells of interest can be identified and then accurately isolated from complex microbial communities based on their SCRS. This approach can be used to sort single cells of target traits from complex samples (e.g., biofilms, soils, sludge, tissues)